UBI — Universal Biosensors Income Statement
0.000.00%
Last trade - 00:00
- AU$38.75m
- AU$22.43m
- AU$6.63m
- 54
- 24
- 42
- 37
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.9 | 3.2 | 5.78 | 4.52 | 6.63 |
Cost of Revenue | |||||
Gross Profit | 3.33 | 0.623 | 2.11 | 2.14 | 4.28 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 17.3 | 15.8 | 20.7 | 39.4 | 23.3 |
Operating Profit | -10.4 | -12.6 | -14.9 | -34.9 | -16.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.16 | -7.64 | -10.5 | -29.9 | -6.74 |
Provision for Income Taxes | |||||
Net Income After Taxes | -4.85 | -7.64 | -10.5 | -26.9 | -6.74 |
Net Income Before Extraordinary Items | |||||
Net Income | -4.85 | -7.64 | -10.5 | -26.9 | -6.74 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -4.85 | -7.64 | -10.5 | -26.9 | -6.74 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.026 | -0.041 | -0.057 | -0.094 | -0.03 |